Debbie Stern, RPh, Vice President, Rxperts Inc, states that the utilization of prior authorizations, developing pathways, and relationships with specialty pharmacies all assist in the management of specialty pharmaceuticals.
Debbie Stern, RPh, Vice President, Rxperts Inc, states that the utilization of prior authorizations, developing pathways, and relationships with specialty pharmacies all assist in the management of specialty pharmaceuticals.
According to Ms. Stern, internal care management components are important when managing patients with high healthcare expenditures. Patient-centered medical homes and accountable care organizations can help develop specific strategies for treating high cost patients.
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More
Disparities in Biomarker Testing Impact Nonsquamous NSCLC Outcomes: Surbhi Singhal, MD
September 6th 2025Surbhi Singhal, MD, of the University of California Davis, discussed disparities in biomarker testing among patients diagnosed with stage IV nonsquamous non–small cell lung cancer (NSCLC).
Read More